AFFILIATIONS
1 University of Rochester, Rochester, New York, United States
2 University of Rochester, Rochester, New York, United States
3 University of Rochester, Rochester, New York, United States
4 Nationwide Children's Hospital, Columbus, Ohio, United States
5 University of Rochester, Rochester, New York, United States
6 Nationwide Children's Hospital, Columbus, Ohio, United States
7 Nationwide Children's Hospital, Columbus, Ohio, United States
8 Nationwide Children's Hospital, Columbus, Ohio, United States
9 University of Rochester, Rochester, New York, United States
10 University of Rochester, Rochester, New York, United States
11 Yale School of Medicine, New Haven, Connecticut, United States
12 Nationwide Children's Hospital, Columbus, Ohio, United States
13 University of Rochester, Rochester, New York, United States
ABSTRACT
Erythropoiesis requires highly coordinated changes in gene expression during rapid cellular proliferation and progressive chromatin condensation. Precise regulation of RNA polymerase II (RNAPII) transcriptional elongation is therefore essential for normal erythroid differentiation. Positive transcription elongation factor b (P-TEFb), a dimer of CDK9 and CCNT1, promotes productive RNAPII elongation by phosphorylating RNAPII, and its associated factors DSIF, and NELF. HEXIM1 has traditionally been viewed as a negative regulator of P-TEFb, because it incorporates P-TEFB into the inhibitory 7SK small nuclear ribonucleoprotein (7SK snRNP) complex, preventing CDK9 activity and restraining RNAPII pause release. Using an inducible erythroid-specific deletion of Hexim1 in mice, we previously demonstrated that that HEXIM1 is essential for erythropoiesis in vivo (Rahman et al. ASH 2025). We have also demonstrated that HEXIM1 is essential for the erythoid differentiation of CD34+ HSPCs, and HUDEP2 cells (Lv et al. Blood. 2023). Importantly, our studies further demonstrate that HEXIM1 unexpectedly localizes to actively transcribed chromatin, suggesting functions beyond global inhibition of transcription (Lv et al. Blood. 2023).
Consistent with this model, analysis of RNAPII occupancy following either HEXIM1 overexpression in HUDEP2 cells or HEXIM1 deletion in an inducible mouse model demonstrated that HEXIM1 selectively redistributes RNAPII across the erythroid genome rather than globally suppressing transcription. To define the molecular mechanisms underlying these observations, we introduced a FLAG epitope into the endogenous HEXIM1 locus by genome editing and performed FLAG immunoprecipitation followed by mass spectrometry. As expected, HEXIM1 interacted with all members of the 7SK snRNP complex. Unexpectedly, HEXIM1 also interacted with multiple components of the Super Elongation Complex (SEC), a transcriptional coactivator that recruits P-TEFb to promoter-proximally paused RNA polymerase II to promote productive transcriptional elongation. Specifically, HEXIM1 interacted with ENL (MLLT1), AFF4, ELL, and ELL2. The interaction between HEXIM1 and ENL was independently validated by co-immunoprecipitation, and found to be partially, but not completely, dependent of the presence of RNA. Notably, deletion of HEXIM1 reduced ENL protein abundance, suggesting that HEXIM1 promotes ENL stability and revealing a previously unrecognized functional link between HEXIM1 and the SEC in the regulation of erythroid gene expression.
To define the structural determinants underlying HEXIM1 interactions with the SEC, we generated a comprehensive panel of HA-tagged HEXIM1 deletion mutants and expressed them in HEXIM1-null K562 cells using the PiggyBac transposon system. The mutant panel systematically interrogated each major functional domain of HEXIM1, including the N-terminal regulatory region, the basic and central domains that bind 7SK RNA and P-TEFb, the PYNT motif required for CDK9 inhibition, the acidic regions, and the C-terminal α-helical domains that mediate CCNT1 binding and HEXIM1 dimerization. Stable clonal pools were established and validated by PCR, sequencing, and immunoblotting. Following HA immunoprecipitation, interactions with P-TEFb, 7SK snRNP, and SEC components were assessed by immunoblotting. Surprisingly, deletion of nearly every major functional domain disrupted association with both 7SK snRNP and SEC components, with the exception of the acidic domains, suggesting that stable assembly of these transcriptional regulatory complexes with HEXIM1 requires the contribution of multiple HEXIM1 domains rather than a single interaction interface.
Together, these studies redefine HEXIM1 as a multifunctional organizer of transcription elongation complexes that coordinates both inhibitory and activating P-TEFb-containing assemblies to direct RNAPII distribution and erythroid gene expression during terminal erythroid differentiation.
DISCLOSURES
Stork O Abruda: No relevant conflicts of interest to declare.